In a significant move to strengthen its global presence, Zinzino has officially finalized an agreement to acquire the assets of Zurvita, a direct-selling healthcare company. The announcement was made in a press release dated December 21, 2024, confirming the completion of the acquisition following Zurvita’s Chapter 11 bankruptcy restructuring.
Zinzino played a key role in Zurvita’s restructuring process, serving as a debtor-in-possession (DIP) financier, providing USD 4.5 million in funding. Upon completion of the restructuring, Zinzino’s offer to acquire Zurvita’s assets was accepted as part of a debt-settled purchase agreement. The final terms of the deal include:
A fixed purchase price of USD 9.4 million, inclusive of the USD 4.5 million DIP financing.
USD 2.5 million of this amount will be settled through newly issued Zinzino shares.
Additional contingent earn-out payments of up to USD 1.9 million, based on sales performance from 2025 to 2029, to be settled in Zinzino shares.
The remaining cash portion will be financed through Zinzino’s existing cash reserves.
With the acquisition, Zinzino gains access to Zurvita’s distribution network, inventory, intellectual property rights, and customer base. Zurvita currently operates in the United States, Canada, and Mexico, with an annual revenue of approximately USD 30 million. The integration into Zinzino’s expanding portfolio is expected to:
Enhance distribution capabilities by leveraging Zinzino’s global reach.
Boost profitability through technological advancements and operational efficiencies.
Strengthen market position in personalized nutrition and health solutions.
This acquisition aligns with Zinzino’s long-term vision of sustainable and profitable growth. The company has a track record of successful acquisitions, including:
VMA Life (2020)
Enhanzz (2022)
Xelliss asset purchase (2024)
Strategic partnership with ACN
By incorporating Zurvita’s assets, Zinzino continues to expand its direct sales leadership in test-based, personalized nutrition. CEO Dag Bergheim Pettersen emphasized this vision:
“Personalized advice and tailored solutions are the future, not just in health and wellness.”
Zurvita’s CEO and co-founder, Jay Shafer, echoed this excitement:
“Together, we bring decades of industry expertise and a shared vision to revolutionize the modern, personalized shopping experience through direct sales.”
Zinzino is a global direct sales company specializing in test-based, personalized nutrition and scientific skincare. Listed on the Nasdaq First North Premier Growth Market, Zinzino’s products are available in over 100 markets worldwide. The company owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as BioActive Foods AS and Faun Pharma AS.
Headquartered in Gothenburg, Sweden, Zinzino also operates additional offices across Europe, Asia, the US, and Australia.
For more information, visit www.zinzino.com.
There are no reviews yet. Be the first one to write one.
